TrialClinical lung cancer2023

Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked.

J Nicholas Bodor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.